Compared Efficacy of Patient-controlled Epidural Analgesia With or Without Automatic Boluses

NCT ID: NCT03407209

Last Updated: 2018-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

462 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-06

Study Completion Date

2018-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epidural analgesia is a significant feature of the everyday experience of the delivery room. Its benefits on the maternal experience and in terms of security has been widely demonstrated.

However, some women under epidural analgesia have experienced motor block, which has been found to contribute in the lengthening of the duration of labor, dystocia and instrumental delivery. Therefore, in recent years, reducing these side effects by modifying local anesthetics, concentration of local anesthetic and injected volume has been a priority, with one aim: optimize analgesia without motor blockage.

Although epidural analgesia was first provided by continuous epidural infusion, the efficacy of intermittent epidural bolus has been demonstrated. Small regularly spaced intermittent boluses lead to a more extensive and symmetrical spread of local anesthetic in the epidural space. These findings have led to a new kind of administration combining epidural intermittent boluses with patient-controlled boluses called PEIB (Patient Epidural Intermittent Bolus). On clinical grounds, PEIB is associated with reduced local anesthetic consumption and higher maternal satisfaction.

While PEIB is experimentally and clinically approved, incidence of maternal motor block and instrumental vaginal delivery don't decrease significantly with this programming. We hypothesized that automatic intermittent boluses can lead to an accumulation of local anesthetic overlapping with patient bolus. This accumulation can be the source of motor block, dystocia and instrumental delivery. Therefore, we propose to lead a monocentric prospective randomized study upon 308 patients in order to compare PEIB to epidural analgesia totally controlled by the patient. We expect a lower consumption of local anesthetic and a lower incidence of motor block, dystocia and instrumental delivery with the free automatic bolus programming.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Local anesthetic used: levobupivacaine 0,625mg/ml

Solution prepared with 200 ml of levobupivacaine 0,625mg/ml associated with analgesic adjuvants: sufentanyl 50 micrograms and clonidine 75 micrograms.

Randomization between:

\- PEIB:

* automatic hourly bolus: 8ml (5mg) on 3 min
* patient controlled bolus: 8ml (5mg) on 3 min
* refractory period: 8min
* continuous infusion: 0
* maximum dose: 65mg/4h

or

\- FREE programming: epidural analgesia totally controlled by the patient

* automatic hourly bolus: 0
* patient controlled bolus: 8ml (5mg) on 3 min
* refractory period: 8min
* continuous infusion: 0
* maximum dose: 65mg/4h

Supervision and care consistent with french expert conference of the SFAR (Société Française d'Anesthésie-Réanimation) on management of women under epidural analgesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delivery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEIB - Use of local levobupivacaine anesthetics: 0.625 mg / ml

* automatic hourly bolus: 8ml (5mg) on 3 min
* patient controlled bolus: 8ml (5mg) on 3 min
* refractory period: 8min
* continuous infusion: 0
* maximum dose: 65mg/4h

Group Type SHAM_COMPARATOR

consumption of local anesthetic measurement

Intervention Type OTHER

consumption of local anesthetic measurement in both groups

FREE programming - levobupivacaine anesthetics: 0.625 mg / ml

Epidural analgesia totally controlled by the patient

* automatic hourly bolus: 0
* patient controlled bolus: 8ml (5mg) on 3 min
* refractory period: 8min
* continuous infusion: 0
* maximum dose: 65mg/4h

Group Type EXPERIMENTAL

consumption of local anesthetic measurement

Intervention Type OTHER

consumption of local anesthetic measurement in both groups

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

consumption of local anesthetic measurement

consumption of local anesthetic measurement in both groups

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent
* Age \>/= 18 years
* Nulliparous
* \>35 weeks of amenorrhea
* In spontaneous or triggered labor

Exclusion Criteria

* Contraindication for epidural analgesia (pre-partum hemostasis troubles, infection)
* Multiple pregnancy
* Fetal death in utero
* Programmed or in emergency caesarian
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Caen University Hopital

Caen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A01346-45

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pocket Warming of Epidural Medication
NCT02912078 ACTIVE_NOT_RECRUITING NA
Deambulatory Epidural During the Labour
NCT02264834 COMPLETED PHASE3